Table 4 shows that high expression of AKT2 and AKT3 were associated with a reduced OS in patients regardless of sex; however, high expression of AKT1 mRNA was not significantly associated with OS in either male or female lung cancer patients. This evidence concerns the gene AKT3 and lung cancer.